MassMutual Private Wealth & Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.1K	Hold	652	–	–	﹤0.01%	1222
2026 Q2	$11.3K	Hold	652	–	–	﹤0.01%	1352
2026 Q1	$8.1K	Hold	652	–	–	﹤0.01%	1452
2025 Q4	$8.22K	Hold	652	–	–	﹤0.01%	1473
2025 Q3	$6.53K	Buy	652 +284	+77%	+$2.55K	﹤0.01%	1573
2025 Q2	$2.98K	Sell	368 -136	-27%	-$1.02K	﹤0.01%	1827
2025 Q1	$4.22K	Buy	504 +380	+306%	+$3.17K	﹤0.01%	1663
2024 Q4	$982	Buy	+124	New	+$1.04K	﹤0.01%	2024
2018 Q3	–	Sell	-52	Closed	-$853	–	972
2018 Q2	$853	Buy	+52	New	+$913	﹤0.01%	1026

Other funds holding AMRX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

MassMutual Private Wealth & Trust's AMRX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 652 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

MassMutual Private Wealth & Trust first reported a position in AMRX in Q2 2018 and has held it in 9 quarters since. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

MassMutual Private Wealth & Trust held 652 shares of Amneal Pharmaceuticals worth $13.1K as of Q3 2026.
MassMutual Private Wealth & Trust left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
Amneal Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1222 holding.
MassMutual Private Wealth & Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 9 quarters since.
264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.